Business Exits recently advised on the successful $130 million sale of a fast-growing healthcare company in the hormone therapy sector, resulting in a strategic partnership with a private equity group focused on healthcare investments.
This transaction was not just a sale—it was a growth-minded deal designed for long-term value creation. The seller retained equity and entered into a new partnership with the buyer to accelerate expansion in the next chapter of the company’s growth.
Transaction Overview
- Industry: Healthcare / Hormone Therapy
- Deal Size: $130,000,000
- Buyer Type: Healthcare-focused Private Equity Group
- Structure: Majority sale with seller rollover equity
Why This Deal Stood Out
Healthcare M&A transactions at this scale demand precision. In this case, multiple layers of complexity had to be addressed simultaneously—from regulatory diligence to deal architecture to data integrity.
Business Exits worked closely with all parties to keep momentum, reduce friction, and ensure the process remained aligned around outcomes that protected value for the seller while giving the buyer confidence to move decisively.
How Business Exits Helped Drive a Successful Outcome
1) Navigating Complex Regulatory Issues
Because the business operated in a highly regulated healthcare environment, diligence required careful handling of compliance documentation, operational controls, and risk mapping. Our team helped coordinate stakeholders and keep regulatory conversations clear, structured, and actionable throughout the process.
2) Structuring the Deal for Alignment
This was not a one-dimensional exit. The seller wanted both liquidity today and upside tomorrow. We helped shape a structure that balanced immediate value realization with retained equity participation, creating alignment between founder and private equity partner for future growth.
3) Supporting Diligence with Data Science and Analytics
One of the most important components of this transaction was the quality of the data package. Business Exits supported deep analytical work to help the buyer evaluate performance drivers, operating trends, and growth opportunities with greater confidence. That data-backed clarity played a meaningful role in accelerating diligence and strengthening conviction.
A Massive Undertaking—and a Strong New Partnership
Closing a $130 million healthcare transaction requires coordinated execution across legal, financial, operational, and strategic workstreams. This deal represented a significant undertaking for everyone involved, and we are proud of the outcome.
We are excited to see both parties prosper in this new partnership and to watch the business continue to scale under a shared vision.
Thinking About Your Own Exit?
If you’re a business owner and want a free business valuation, email Partner Robert directly at [email protected].
If you’re a buyer, view current opportunities and join our email list at businessexits.com/listings.
Business Exits advises founders on strategic exits, recapitalizations, and growth partnerships across lower middle market and middle market transactions.